ConductScience.org, home

Paper35411997

Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.

Davies MA and 46 others. Trop Med Int Health, 2022. Cited by 109 papers, by iCite.

Cite this record

ConductScience Library. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Papers, record 35411997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35411997

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
PubMed
Journal
Trop Med Int Health
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
109
iCite
Relative citation ratio, by iCite
5.72
iCite
Revised in PubMed
2025-05-30
PubMed

Authors47

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Davies MAMary-Ann
2Kassanjee RReshma
3Rousseau PPetro
4Morden EErna
5Johnson LLeigh
6Solomon WWesley
7Hsiao NYNei-Yuan
8Hussey HHannah
9Meintjes GGraeme
10Paleker MMasudah
11Jacobs TTheuns
12Raubenheimer PPeter
13Heekes AAlexa
14Dane PPierre
15Bam JLJamy-Lee
16Smith MMariette
17Preiser WWolfgang
18Pienaar DDavid
19Mendelson MMarc
20Naude JJonathan

Source PubMed

See all 47 authorsDownload CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Clinical Laboratory TechniquesMajor topic
SARS-CoV-2Major topic
Adult
COVID-19 Testing
COVID-19 Vaccines
Cohort Studies
Female
Humans
Male
Seroepidemiologic Studies
South Africa
Young Adult

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
203135/Z/16/ZWellcome TrustUnited KingdomPubMedPubMed
FC0010218Wellcome TrustUnited KingdomPubMedPubMed
INV-017293Gates FoundationUnited StatesPubMedPubMed
R01 HD080465NICHD NIH HHSUnited StatesR01HD080465PubMed and NIHNIH RePORTER
1191327Gates FoundationUnited StatesPubMedPubMed
1164272Gates FoundationUnited StatesPubMedPubMed
214321/Z/18/ZWellcome TrustUnited KingdomPubMedPubMed
FC0010218Cancer Research UKUnited KingdomPubMedPubMed
FC0010218Medical Research CouncilUnited KingdomPubMedPubMed
222574Wellcome TrustUnited KingdomPubMedPubMed
U01 AI069924NIAID NIH HHSUnited StatesU01AI069924PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of35043121

Source PubMed

Download CSV of comments and corrections

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135411997Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.Trop Med Int Health2022https://conductscience.org/library/papers/35411997PubMed
234882437Track Omicron's spread with molecular data.Science2021https://conductscience.org/library/papers/34882437PubMed
334967859Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves.JAMA2022https://conductscience.org/library/papers/34967859PubMed
434487704Hospitalisation associated with SARS-CoV-2 delta variant in Denmark.Lancet Infect Dis2021https://conductscience.org/library/papers/34487704PubMed
535289632Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.Science2022https://conductscience.org/library/papers/35289632PubMed
634286217Higher COVID-19 mortality in low-income communities in the City of Cape Town - a descriptive ecological study.Gates Open Res2021https://conductscience.org/library/papers/34286217PubMed
734252381Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study.Lancet Glob Health2021https://conductscience.org/library/papers/34252381PubMed
832860699Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.Clin Infect Dis2021https://conductscience.org/library/papers/32860699PubMed
937994361Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study.Gates Open Res2022https://conductscience.org/library/papers/37994361PubMed
1035062015SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.Nature2022https://conductscience.org/library/papers/35062015PubMed
1135066015The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.Antiviral Res2022https://conductscience.org/library/papers/35066015PubMed
1235196424Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.N Engl J Med2022https://conductscience.org/library/papers/35196424PubMed
1334461056Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.Lancet Infect Dis2022https://conductscience.org/library/papers/34461056PubMed
1435042229Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.Nature2022https://conductscience.org/library/papers/35042229PubMed
1532935043Data Centre Profile: The Provincial Health Data Centre of the Western Cape Province, South Africa.Int J Popul Data Sci2019https://conductscience.org/library/papers/32935043PubMed
1634423834
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta).
Clin Infect Dis2022https://conductscience.org/library/papers/34423834PubMed
1735104837Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.Nature2022https://conductscience.org/library/papers/35104837PubMed
1834477548SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.Emerg Infect Dis2021https://conductscience.org/library/papers/34477548PubMed
1935065011Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.Lancet2022https://conductscience.org/library/papers/35065011PubMed

Download CSV of references

Cited by95

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.

PMIDTitleJournalYearIn PapersSource
41264585Concern for severe COVID-19 disease during the initial two years of pandemic in a rural South African community: A population-based study.PLoS One2025https://conductscience.org/library/papers/41264585PubMed
40872876Challenges to the Effectiveness and Immunogenicity of COVID-19 Vaccines: A Narrative Review with a Systematic Approach.Vaccines (Basel)2025https://conductscience.org/library/papers/40872876PubMed
40057834Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh.J Glob Health2024https://conductscience.org/library/papers/40057834PubMed
39758969Increased gastrointestinal bleeding-related mortality during the COVID-19 pandemic.Ther Adv Gastroenterol2025https://conductscience.org/library/papers/39758969PubMed
39593005Clinical characteristics and booster vaccine effectiveness of the Omicron variant.BMC Infect Dis2024https://conductscience.org/library/papers/39593005PubMed
39578871Clinical outcomes of Omicron infection and vaccine acceptance among pediatric liver transplant recipients: insights from a cross-sectional survey.Virol J2024https://conductscience.org/library/papers/39578871PubMed
39106267SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities.PLOS Glob Public Health2024https://conductscience.org/library/papers/39106267PubMed
39090598Acute and long COVID-19 symptoms and associated factors in the omicron-dominant period: a nationwide survey via the online platform Wenjuanxing in China.BMC Public Health2024https://conductscience.org/library/papers/39090598PubMed
39020307
A prospective randomised controlled trial investigating household SARS-CoV-2 transmission in a densely populated community in Cape Town, South Africa - the transmission of COVID-19 in crowded environments (TRACE) study.
BMC Public Health2024https://conductscience.org/library/papers/39020307PubMed
38971737Impact of non-emergency surgical timing on postoperative recovery quality in mild or asymptomatic SARS-CoV-2 infected patients: a grouped cohort study.BMC Anesthesiol2024https://conductscience.org/library/papers/38971737PubMed
38742290Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study.J Korean Med Sci2024https://conductscience.org/library/papers/38742290PubMed
38675745SARS-CoV-2 Neutralizing Antibodies in Three African Countries Following Multiple Distinct Immune Challenges.Vaccines (Basel)2024https://conductscience.org/library/papers/38675745PubMed
38450129Comparing COVID-19 severity in patients hospitalized for community-associated Delta, BA.1 and BA.4/5 variant infection.Front Public Health2024https://conductscience.org/library/papers/38450129PubMed
38157194Pathogen evolution, prevention/control strategy and clinical features of COVID-19: experiences from China.Front Med2023https://conductscience.org/library/papers/38157194PubMed
37994361Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study.Gates Open Res2022https://conductscience.org/library/papers/37994361PubMed
37907849Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service.BMC Infect Dis2023https://conductscience.org/library/papers/37907849PubMed
37821945Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity.Eur J Med Res2023https://conductscience.org/library/papers/37821945PubMed
37766248Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated Factors.Viruses2023https://conductscience.org/library/papers/37766248PubMed
37748932A risk science perspective on vaccines.Risk Anal2024https://conductscience.org/library/papers/37748932PubMed
37738280Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves.PLoS One2023https://conductscience.org/library/papers/37738280PubMed

See all 95 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35411997

GET https://conductscience.org/api/papers/v1/35411997/authors?page=2